https://www.selleckchem.com/CDK.html
To measure the rate of recall of study participation and study attrition in survivors of acute respiratory distress syndrome(ARDS). In this ancillary study of the Re-evaluation of Systemic Early neuromuscular blockade(ROSE) trial, we measured the rate of study participation recall 3 months following discharge and subsequent study attrition at 6 months. We compared patient and hospital characteristics, and long-term outcomes by recall. As surrogate decision-makers provided initial consent, we measured the rate of patient reconsent and its association
Like
Comment
Share
